Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Apr 28:9:2050313X211011813.
doi: 10.1177/2050313X211011813. eCollection 2021.

Intralesional fenestration and corticosteroid injection for symptomatic Ledderhose disease of the foot: Two case reports

George Flanagan  1 , Nicola Burt  1 , Ian N Reilly  1
Affiliations
Case Reports

Intralesional fenestration and corticosteroid injection for symptomatic Ledderhose disease of the foot: Two case reports

George Flanagan et al. SAGE Open Med Case Rep. .

Abstract

The description of corticosteroid injections as a treatment option for Ledderhose disease has received little attention in the literature and often only receives a passing comment in scientific papers. We present a short case series of two patients who underwent corticosteroid injection in combination with fenestration to treat painful Ledderhose disease nodules. Both patients had their lesions injected on two occasions. Significant reduction in pain and lesion volume was seen at 12 months post treatment. Our protocol combines fenestration with the use of triamcinolone acetonide (mixed with local anaesthetic) which we believe conveys further advantage over other steroid preparations or the corticosteroid infiltration alone.

Keywords: Ledderhose disease; corticosteroid injection; fenestration; needling; peppering; plantar fibromatosis; triamcinolone.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The senior author (G.F.) is a consultant for the British Dupuytren’s Society.

Figures

Figure 1.
Figure 1.
Case 1 USS pre-injection (larger, distal lesion).
Figure 2.
Figure 2.
Case 1 USS pre-injection (smaller, proximal lesion).
Figure 3.
Figure 3.
Case 1: second injection without USS. We find that a medial approach rather than a plantar approach is more comfortable for the patient.
Figure 4.
Figure 4.
Case 1: USS post second injection (larger, distal lesion).
Figure 5.
Figure 5.
Case 1: USS post second injection (smaller, proximal lesion).
Figure 6.
Figure 6.
Case 2: USS pre-injection.
Figure 7.
Figure 7.
Case 2: USS post injection.
See this image and copyright information in PMC

References

    1. Walker EA, Petscavage JM, Brian PL, et al. Imaging features of superficial and deep fibromatoses in the adult population. Sarcoma 2012; 2012: 215810. - PMC - PubMed
    1. Goldblum JR, Weiss SW, Folpe AL. Benign fibroblastic/myofibroblastic proliferations, including superficial fibromatoses in Enzinger and Weiss’s soft tissue tumors. 7th ed. Amsterdam: Elsevier Health Sciences, 2019, pp. 260–263.
    1. DeBrule MB, Mott RC, Funk C, et al. Osseous metaplasia in plantar fibromatosis: a case report. J Foot Ankle Surg 2004; 43(6): 430–432. - PubMed
    1. Ledderhose G. Über zerreisungen der plantarfascie. Arch Klin Chir 1894; 48: 853–856.
    1. Espert M, Anderson MR, Baumhauer JF. Current concepts review: plantar fibromatosis. Foot Ankle Int 2018; 39(6): 751–757. - PubMed

Publication types

LinkOut - more resources